Spinal Cord Stimulation for Spinal Cord Injury
AM
Overseen ByAndrea Maharaj, BSc
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of British Columbia
No Placebo Group
Trial Summary
What is the purpose of this trial?
The aim of this study is to examine the mechanisms of transcutaneous spinal cord stimulation (tSCS) for improving cardiovascular and pulmonary function in individuals with chronic motor-complete spinal cord injury (SCI) by measuring vascular related endothelial biomarkers, plasma catecholamines, and respiratory parameters.
Research Team
Andrei Krassioukov, MD,PhD,FRCPC
Principal Investigator
University of British Columbia
Eligibility Criteria
This trial is for individuals with chronic motor-complete spinal cord injury who are interested in exploring how a non-invasive treatment called transcutaneous spinal cord stimulation (tSCS) might improve their heart and lung function.Inclusion Criteria
Resident of British Columbia, Canada with active provincial medical services plan
It has been over a year since my injury or diagnosis and at least 6 months since any spinal surgery.
Willing and able to comply with all clinic visits and study-related procedures
See 9 more
Exclusion Criteria
Presence of severe acute medical issue(s) that in the investigator's judgement would adversely affect the participant's participation in the study (e.g., pressure sore, urinary tract infection, etc.)
Clinically significant, unmanaged, depression (PHQ-9 above 15) or ongoing drug abuse
Use of any medication or treatment that in the opinion of the investigator indicates that it is not in the best interest of the participant to participate in this study
See 8 more
Treatment Details
Interventions
- Transcutaneous Spinal Cord Stimulation (tSCS) (Device)
Trial OverviewThe study tests the effects of tSCS on cardiovascular and pulmonary health by monitoring changes in blood vessel-related markers, stress hormones in the blood, and breathing measurements.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Transcutaneous spinal cord stimulation (tSCS)Experimental Treatment1 Intervention
Exploring the mechanisms of SCS for improving cardiovascular function in individuals with chronic, motor-complete SCI by measuring vascular related endothelial biomarkers and plasma catecholamines
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Trials
1,506
Recruited
2,528,000+